Cargando…
The Shinyanga Patient: A Patient’s Journey through HIV Treatment Cascade in Rural Tanzania
The 2016–2017 Tanzania HIV Impact Survey (THIS) reported the accomplishments towards the 90-90-90 global HIV targets at 61-94-87, affirming the need to focus on the first 90 (i.e., getting 90% of people living with HIV (PLHIV) tested). We conducted a patient-pathway analysis to understand the gap ob...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393654/ https://www.ncbi.nlm.nih.gov/pubmed/34444166 http://dx.doi.org/10.3390/ijerph18168418 |
_version_ | 1783743775150964736 |
---|---|
author | Okere, Nwanneka E Sambu, Veryeh Ndungile, Yudas van Praag, Eric Hermans, Sabine Naniche, Denise de Wit, Tobias F Rinke Maokola, Werner Gomez, Gabriela B |
author_facet | Okere, Nwanneka E Sambu, Veryeh Ndungile, Yudas van Praag, Eric Hermans, Sabine Naniche, Denise de Wit, Tobias F Rinke Maokola, Werner Gomez, Gabriela B |
author_sort | Okere, Nwanneka E |
collection | PubMed |
description | The 2016–2017 Tanzania HIV Impact Survey (THIS) reported the accomplishments towards the 90-90-90 global HIV targets at 61-94-87, affirming the need to focus on the first 90 (i.e., getting 90% of people living with HIV (PLHIV) tested). We conducted a patient-pathway analysis to understand the gap observed, by assessing the alignment between where PLHIV seek healthcare and where HIV services are available in the Shinyanga region, Tanzania. We used existing and publicly available data from the National AIDS Control program, national surveys, registries, and relevant national reports. Region-wide, the majority (n = 458/722, 64%) of THIS respondents accessed their last HIV test at public sector facilities. There were 65.9%, 45.1%, and 74.1% who could also access antiretroviral therapy (ART), CD4 testing, and HIV viral load testing at the location of their last HIV test, respectively. In 2019, the viral suppression rate estimated among PLHIV on ART in the Shinyanga region was 91.5%. PLHIV access HIV testing mostly in public health facilities; our research shows that synergies can be achieved to improve access to services further down the cascade in this sector. Furthermore, effective engagement with the private sector (not-for-profit and for-profit) will help to achieve the last mile toward ending the HIV epidemic. |
format | Online Article Text |
id | pubmed-8393654 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83936542021-08-28 The Shinyanga Patient: A Patient’s Journey through HIV Treatment Cascade in Rural Tanzania Okere, Nwanneka E Sambu, Veryeh Ndungile, Yudas van Praag, Eric Hermans, Sabine Naniche, Denise de Wit, Tobias F Rinke Maokola, Werner Gomez, Gabriela B Int J Environ Res Public Health Article The 2016–2017 Tanzania HIV Impact Survey (THIS) reported the accomplishments towards the 90-90-90 global HIV targets at 61-94-87, affirming the need to focus on the first 90 (i.e., getting 90% of people living with HIV (PLHIV) tested). We conducted a patient-pathway analysis to understand the gap observed, by assessing the alignment between where PLHIV seek healthcare and where HIV services are available in the Shinyanga region, Tanzania. We used existing and publicly available data from the National AIDS Control program, national surveys, registries, and relevant national reports. Region-wide, the majority (n = 458/722, 64%) of THIS respondents accessed their last HIV test at public sector facilities. There were 65.9%, 45.1%, and 74.1% who could also access antiretroviral therapy (ART), CD4 testing, and HIV viral load testing at the location of their last HIV test, respectively. In 2019, the viral suppression rate estimated among PLHIV on ART in the Shinyanga region was 91.5%. PLHIV access HIV testing mostly in public health facilities; our research shows that synergies can be achieved to improve access to services further down the cascade in this sector. Furthermore, effective engagement with the private sector (not-for-profit and for-profit) will help to achieve the last mile toward ending the HIV epidemic. MDPI 2021-08-09 /pmc/articles/PMC8393654/ /pubmed/34444166 http://dx.doi.org/10.3390/ijerph18168418 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Okere, Nwanneka E Sambu, Veryeh Ndungile, Yudas van Praag, Eric Hermans, Sabine Naniche, Denise de Wit, Tobias F Rinke Maokola, Werner Gomez, Gabriela B The Shinyanga Patient: A Patient’s Journey through HIV Treatment Cascade in Rural Tanzania |
title | The Shinyanga Patient: A Patient’s Journey through HIV Treatment Cascade in Rural Tanzania |
title_full | The Shinyanga Patient: A Patient’s Journey through HIV Treatment Cascade in Rural Tanzania |
title_fullStr | The Shinyanga Patient: A Patient’s Journey through HIV Treatment Cascade in Rural Tanzania |
title_full_unstemmed | The Shinyanga Patient: A Patient’s Journey through HIV Treatment Cascade in Rural Tanzania |
title_short | The Shinyanga Patient: A Patient’s Journey through HIV Treatment Cascade in Rural Tanzania |
title_sort | shinyanga patient: a patient’s journey through hiv treatment cascade in rural tanzania |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393654/ https://www.ncbi.nlm.nih.gov/pubmed/34444166 http://dx.doi.org/10.3390/ijerph18168418 |
work_keys_str_mv | AT okerenwannekae theshinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania AT sambuveryeh theshinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania AT ndungileyudas theshinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania AT vanpraageric theshinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania AT hermanssabine theshinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania AT nanichedenise theshinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania AT dewittobiasfrinke theshinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania AT maokolawerner theshinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania AT gomezgabrielab theshinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania AT okerenwannekae shinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania AT sambuveryeh shinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania AT ndungileyudas shinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania AT vanpraageric shinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania AT hermanssabine shinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania AT nanichedenise shinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania AT dewittobiasfrinke shinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania AT maokolawerner shinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania AT gomezgabrielab shinyangapatientapatientsjourneythroughhivtreatmentcascadeinruraltanzania |